Lete-Cel
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Lete-Cel, covering 2023-10-16 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma [Phase 2]